RU2010112813A - APPLICATION OF THE BIONUCLEAR SULFUR-NITROZYL IRON COMPLEX OF THE CATION TYPE AS A VASODILATOR MEDICINE - Google Patents
APPLICATION OF THE BIONUCLEAR SULFUR-NITROZYL IRON COMPLEX OF THE CATION TYPE AS A VASODILATOR MEDICINE Download PDFInfo
- Publication number
- RU2010112813A RU2010112813A RU2010112813/15A RU2010112813A RU2010112813A RU 2010112813 A RU2010112813 A RU 2010112813A RU 2010112813/15 A RU2010112813/15 A RU 2010112813/15A RU 2010112813 A RU2010112813 A RU 2010112813A RU 2010112813 A RU2010112813 A RU 2010112813A
- Authority
- RU
- Russia
- Prior art keywords
- iron complex
- sulfur
- nitrozyl
- bionuclear
- application
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Применение биядерного сера-нитрозильного комплекса железа катионного типа [Fe2(SC5H11NO2)2(NO)4]·5H2O в качестве вазодилататорного лекарственного средства. ! 2. Применение биядерного сера-нитрозильного комплекса железа катионного типа [Fe2(SC5H11NO2)2(NO)4]·5H2O для получения лекарственного средства для лечения ишемического заболевания. 1. The use of binuclear sulfur-nitrosyl iron complex of the cationic type [Fe2 (SC5H11NO2) 2 (NO) 4] · 5H2O as a vasodilator drug. ! 2. The use of the binuclear sulfur-nitrosyl iron complex of the cationic type [Fe2 (SC5H11NO2) 2 (NO) 4] · 5H2O for the manufacture of a medicament for the treatment of ischemic disease.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010112813/15A RU2460531C2 (en) | 2010-04-05 | 2010-04-05 | Use of binuclear sulphur-nitrosyl cationic iron complex as vasodilatator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010112813/15A RU2460531C2 (en) | 2010-04-05 | 2010-04-05 | Use of binuclear sulphur-nitrosyl cationic iron complex as vasodilatator |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010112813A true RU2010112813A (en) | 2011-10-10 |
RU2460531C2 RU2460531C2 (en) | 2012-09-10 |
Family
ID=44804713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010112813/15A RU2460531C2 (en) | 2010-04-05 | 2010-04-05 | Use of binuclear sulphur-nitrosyl cationic iron complex as vasodilatator |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2460531C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2522953C1 (en) * | 2013-06-14 | 2014-07-20 | Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения Российской Федерации (ФГБУ "РКНПК" Минздрава России) | Agent against myocardial hypoxia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2291880C1 (en) * | 2005-12-01 | 2007-01-20 | Институт химической физики им. Н.Н. Семенова РАН (ИХФ РАН) | Polymer composition for preparing stabilized form of iron dinitrozyl complex and a method for preparing indicated form of complex |
WO2008147242A1 (en) * | 2007-05-30 | 2008-12-04 | Institut Problem Khimicheskoi Fiziki Rossiiskoi Akademii Nauk | Use of a tetra-nitrosyl-iron complex with thiophenol as an antitumoral medicinal agent |
-
2010
- 2010-04-05 RU RU2010112813/15A patent/RU2460531C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2460531C2 (en) | 2012-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014501702A1 (en) | Imidazopyrrolidinone compounds | |
NZ706853A (en) | Vegf neutralizing prodrugs for the treatment of ocular conditions | |
UA115122C2 (en) | Cd3-binding molecules capable of binding to human and non-human cd3 | |
MX356728B (en) | Pharmaceutical combination for use in the treatment of diabetes type 2. | |
EA201491299A1 (en) | CARBAMATIC CONNECTIONS, THEIR PRODUCTION AND APPLICATION | |
EA029089B9 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
MX2014015346A (en) | Reversible covalent pyrrolo- or pyrazolopyrimidines useful for the treatment cancer and autoimmune diseases. | |
EA201590200A1 (en) | MODULATORS OF THE COMPLEMENT ACTIVATION WAY AND THEIR APPLICATION | |
IN2012DN06720A (en) | ||
HK1148202A1 (en) | Pharmaceutical solutions, process of preparation and therapeutic uses | |
MX344238B (en) | Tetrazole compounds and methods of making and using same. | |
PH12014501334A1 (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | |
UY32444A (en) | COMPOSITIONS AND PROCEDURES FOR EXTENDED THERAPY WITH AMINOPIRIDINS | |
PH12015502365B1 (en) | Bace1 inhibitors | |
TN2012000457A1 (en) | Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias | |
MX2015004362A (en) | Ketamine derivatives. | |
MX369717B (en) | Benzamides. | |
CO6470899A2 (en) | 2,4-DIAMINOPIRIMIDINES FOR THE TREATMENT OF CHARACTERIZED DISEASES BY EXCESSIVE OR NORMAL CELL PROLIFERATION | |
PH12014502484A1 (en) | Oligonucleotide chelate complex methods | |
GB201209587D0 (en) | Therapeutic compounds | |
NZ702254A (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
UY35253A (en) | PHARMACEUTICAL COMPOUND FOR THE PREVENTION AND TREATMENT OF A COGNITI VOS, NEURODEGENERATIVE OR NEURONAL DISEASE | |
MX2018004696A (en) | Epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates thereof. | |
RU2010112813A (en) | APPLICATION OF THE BIONUCLEAR SULFUR-NITROZYL IRON COMPLEX OF THE CATION TYPE AS A VASODILATOR MEDICINE | |
MX365292B (en) | 5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines. |